Have you recently been diagnosed with cancer after regularly taking Zantac, the popular heartburn medication? You may be entitled to legal compensation. Duncan Firm, with offices in Little Rock, Arkansas, Los Angeles, California and New York, is accepting clients seeking damages for medical expenses and other losses linked to a Zantac-related cancer diagnosis. In California, we are also accepting clients that may have also taken a generic version of Zantac and been diagnosed with certain types of cancers.
Zantac (ranitidine) is an over-the-counter antacid and antihistamine that is usually taken to treat or prevent acid reflux, also known as heartburn. It is also sometimes used to treat stomach ulcers and gastroesophageal reflux disease (GERD), and is available in prescription and over-the-counter versions. Your doctor may have prescribed it or recommended you take it to treatment those symptoms.
However, on September 13, 2019, the U.S. Food and Drug Administration (FDA) announced the discovery of a carcinogenic contaminant in Zantac: N-nitrosodimethylamine (NDMA). NDMA is a widely known dangerous chemical that is used in industrial lubricants, as well as aviation and rocket fuel. It is a byproduct of industrial processes like gasoline refining and wastewater treatment. The cancer-causing properties of NDMA are so well-known that it is used in cancer research to induce the formation of cancer cells in laboratory rats, a process called carcinogenesis.
In addition to causing cancer, NDMA is a hepatotoxin, a toxic substance that damages the liver. Short-term exposure can cause liver fibrosis and scarring, and long-term exposure leads to a host of symptoms such as headaches, nausea, fever, vomiting, abdominal cramps, and reduced function of the lungs, kidneys, and liver.
The cause of the NDMA contamination is likely related to the manufacturing methods of some suppliers of Zantac. The FDA formally issued a recall on April 1, 2020 and removed Zantac and its generic versions of the drug from being sold.
In February 2020, the United States District Court for the Southern District of Florida established an MDL (multidistrict litigation) for Zantac lawsuits nationwide. More than 140 lawsuits were pending as of March 2020.
Plaintiffs are accusing Zantac manufacturer Sanofi of marketing and selling a product they know or should have known had been contaminated with a dangerous carcinogenic substance. At the time, no large mass tort settlements have been awarded, but could be soon.
If you suspect a connection between your cancer diagnosis and recent intake of Zantac, Duncan Firm is prepared to seek the following damages for you:
A cancer diagnosis can change the course of your life. It can result in exorbitant medical expenses, lost wages, and a general loss of enjoyment of life. Fortunately, legal remedies are available if your cancer is linked to the negligence of a company that knowingly exposed you to dangerous substances. If you have regularly used Zantac and been diagnosed with:
Contact Duncan Firm immediately for a consultation.